Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

被引：0
|
作者：
Rollison, Dana E. [1 ]
Shain, Kenneth H. [1 ]
Lee, Ji-Hyun [2 ]
Hampras, Shalaka S. [1 ]
Fisher, Kate [1 ]
Al Ali, Najla H. [1 ]
Padron, Eric [3 ]
Lancet, Jeff E. [1 ]
Olesnyckyj, Marta [4 ]
Kenvin, Laurie [4 ]
Knight, Robert D. [4 ]
Dalton, William [1 ]
List, Alan F. [1 ]
Komrokji, Rami [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] Celgene Corp, Summit, NJ USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide
    Rollison, Dana E.
    Shain, Kenneth H.
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey
    Xu, Qiang
    Olesnyckyj, Martha
    Kenvin, Laurie
    Knight, Robert
    Dalton, William
    List, Alan
    Komrokji, Rami S.
    CANCER MEDICINE, 2016, 5 (07): : 1694 - 1701
  • [2] Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert D.
    Sullivan, Daniel M.
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    BLOOD, 2014, 124 (21)
  • [3] Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Xu, Qiang
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert
    Sullivan, Daniel
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 560 - 568
  • [4] Venous thromboembolism in patients with myelodysplastic syndrome treated with lenalidomide: Incidence and risk factors
    Brandenburg, N. A.
    Weiss, L.
    Bwire, R.
    Schmidt, M.
    Knight, R.
    List, A. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
    A C Chan
    P Neeson
    E Leeansyah
    K Tainton
    H Quach
    H M Prince
    D I Godfrey
    D Ritchie
    S P Berzins
    Leukemia, 2010, 24 : 592 - 600
  • [6] Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
    Chan, A. C.
    Neeson, P.
    Leeansyah, E.
    Tainton, K.
    Quach, H.
    Prince, H. M.
    Godfrey, D. I.
    Ritchie, D.
    Berzins, S. P.
    LEUKEMIA, 2010, 24 (03) : 592 - 600
  • [7] Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes
    Giagounidis, Aristoteles
    Raza, Azra
    List, Alan F.
    Fenaux, Pierre
    Benettaib, Bouchra
    Brown, Benton
    Zhong, Jim
    Brandenburg, Nancy
    Mufti, Ghulam J.
    BLOOD, 2011, 118 (21) : 742 - 743
  • [8] Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)
    Adema, Vera
    Palomo, Laura
    Fuster-Tormo, Francisco
    Benito, Rocio
    Salgado, Rocio
    Such, Esperanza
    Kosmider, Olivier
    Larrayoz, Maria Jose
    Xicoy, Blanca
    Janusz, Kamila
    Maietta, Paolo
    Neef, Alexander
    Amunchastegui, Beatriz Arrizabalaga
    Fontenay, Michaela
    Gomez-Marzo, Paula
    Del Rey, Monica
    Ibanez, Mariam
    Haro, Nuri
    Mallo, Mar
    Zamora, Lurdes
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Cervera, Jose
    Calasanz, Maria Jose
    Hernandez-Rivas, Jesus Maria
    Cigudosa, Juan
    Sole, Francesc
    BLOOD, 2016, 128 (22)
  • [9] Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective
    Fung, Katherine
    Duggan, Peter
    Chambers, Carole
    Yau, Patrick Shui-Lun
    Dersch-Mills, Deonne
    Cusano, Frances
    Bahlis, Nizar J.
    Ghosh, Sunita
    BLOOD, 2016, 128 (22)
  • [10] Investigation of Second Primary Malignancies (SPM) in Multiple Myeloma (MM) Patients Treated with Lenalidomide
    Minton, N.
    Castaneda, C.
    Weiss, L.
    Brandenburg, N.
    Gary, D.
    Freeman, J.
    Delap, R.
    Knight, R.
    Glasmacher, A.
    Rupalla, K.
    Zhang, J.
    Yu, Z.
    DRUG SAFETY, 2011, 34 (10) : 951 - 951
12345